In the age of COVID-19, the last thing anyone wants is to schedule a doctor’s visit. Thanks to Noor Sweid’s Global Ventures, managing our health remotely is likely to get easier due to emerging market regional companies.
Global Ventures is now exploring opportunities in healthcare technology, with an eye on founders whose technologies are meeting increased demand for telemedicine and diagnostics in emerging markets in the wake of COVID-19.
Global Ventures most recent venture capital fund closed in December 2019 with $50 million. As of March, the fund’s capital was . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
Monthly
$30
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
→ Access to the weekly AW Deal Watch by AW Research
Annual
$300
Required for access to AW Research
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators
